Indication (nā=ā1127) | No. (%) |
1999 guideline recommended | 376 (33.4) |
Known ANCA associated small vessel vasculitis | 67 (5.9) |
AIH, PSC or other liver disease | 54 (4.8) |
Inflammatory bowel disease | 50 (4.4) |
Churg Strauss syndrome | 30 (2.7) |
Follow up of previously positive ANCA | 14 (1.2) |
Indication not covered above | 536 (47.6) |
AIH, autoimmune hepatitis; PSC, primary sclerosing cholangitis.